Trial Lecture – time and place
See Trial Lecture.
Adjudication committee
- First opponent: Neonatologist Christian Hulzebos, Beatrix Children's Hospital
- Second opponent: Speciality Registrar Pernille Vandborg, Regionhospital Viborg
- Third member and chair of the evaluation committee: Professor Emeritus Ola Didrik Saugstad, University of Oslo
Chair of the Defence
Professor II Guttorm Haugen, University of Oslo
Principal Supervisor
Professor Emeritus Thor Willy Ruud Hansen, University of Oslo
Summary
Khalaf Mreihil has studied the effect of phototherapy for neonatal jaundice on the formation of water-soluble substances (bilirubin photoisomers) that theoretically are believed to be brain protective. In addition, he has studied the use of phototherapy in daily practice in all neonatal intensive care units in Norway. He found that the formation of water-soluble substances starts as soon as phototherapy lights are turned on, and that, in spite of national guidelines, there is wide variation in the practical use of phototherapy for newborn infants in Norway
Additional information
Contact the research support staff.